Fraud and misconduct in medical research

Abstract

British Journal of Clinical PharmacologyVolume 43, Issue 1 p. 3-7 Free Access Fraud and misconduct in medical research Frank Wells, Frank Wells 3 The Granaries, Tuddenham St Martin, Ipswich 1P6 9BW, UKSearch for more papers by this author Frank Wells, Frank Wells 3 The Granaries, Tuddenham St Martin, Ipswich 1P6 9BW, UKSearch for more papers by this author First published: 18 July 2008 https://doi.org/10.1111/j.1365-2125.1997.tb00129.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Brock P. A pharmaceutical company's approach. In Fraud and Misconduct in Medical Research (ed SP Lock, FO Wells) 1996 London : BMJ Publishing Group. 2 Dyer O. GP struck off for fraud in drug trials. Br Med J 1996; 312: 643. 3 Swan N. Preventing and dealing with scientific fraud in Australia. Med J Aust 1989; 150: 169– 170. 4 Lock SP. Lessons from the Pearce affair: handling scientific fraud. Br Med J 1995; 310: 1547– 1548. 5 Association of the British Pharmaceutical Industry. Report on fraud and misconduct in clinical research. London : ABPI, 1992. 6 Royal College of Physicians of London. Report on fraud and misconduct in medical research. London : RCP, 1991. 7 Editorial. Dealing with deception. Lancet 1996; 347: 843. 8 Association of the British Pharmaceutical Industry. Guidelines for investigators on good clinical (research) practice. London : ABPI, 1996. 9 Association of the British Pharmaceutical Industry. Good Clinical Research Practice Guidelines. London : ABPI, 1988. 10 European Commission. Good Clinical Practice Guidelines. Brussels : EC, 1991. 11 International Conference on Harmonisation: Guidelines on Good Clinical Practices. Geneva : IFPMA, 1996. 12 Association of the British Pharmaceutical Industry. Statistical methods in the investigation of fraud. London : ABPI, 1993. 13 SP Lock, FO. Wells (eds). Fraud and Misconduct in Medical Research. London : BMJ Publishing Group, 1996. Citing Literature Volume43, Issue1January 1997Pages 3-7 ReferencesRelatedInformation